Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Jing Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7604-6732; OpenAlex author ID A5100778832. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Targeting PIKfyve-driven lipid metabolism in pancreatic cancer. First author DOI 10.1038/s41586-025-08917-z↗
  2. A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma. Co-author DOI 10.1186/1756-8722-4-11↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dominik Awad · 1 shared paper, 2025 · strength 0.17
  2. Marina Pasca di Magliano · 1 shared paper, 2025 · strength 0.17
  3. Arul M. Chinnaiyan · 1 shared paper, 2025 · strength 0.17
  4. Jennifer P. Morton · 1 shared paper, 2025 · strength 0.17
  5. Vaibhav Sahai · 1 shared paper, 2025 · strength 0.17
  6. Caleb Cheng · 1 shared paper, 2025 · strength 0.17
  7. Li Zhang · 1 shared paper, 2025 · strength 0.17
  8. Costas Andreas Lyssiotis · 1 shared paper, 2025 · strength 0.17
  9. Yue Ma · 1 shared paper, 2011 · strength 0.03
  10. Fengchun Zhang · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.